Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
87.04 USD
-1.07%
Market Closed
Updated:
May 29, 2024
Edwards Lifesciences Corp
Capital Expenditures
|
Edwards Lifesciences Corp
Capital Expenditures Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Capital Expenditures
-$266.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-12%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Capital Expenditures
-$735m
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$779m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-10%
|
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$612m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$1.1B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-26%
|
See Also
What is Edwards Lifesciences Corp's Capital Expenditures?
Capital Expenditures
-266.3m
USD
-266.3m
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Capital Expenditures amounts to -266.3m USD.
What is Edwards Lifesciences Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-12%
-12%
Over the last year, the Capital Expenditures growth was -5%. The average annual Capital Expenditures growth rates for Edwards Lifesciences Corp have been 15% over the past three years , -1% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
